nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A5—Disulfiram—alcohol dependence	0.246	0.475	CbGbCtD
Lercanidipine—CYP2D6—Citalopram—alcohol dependence	0.107	0.208	CbGbCtD
Lercanidipine—CYP3A4—Disulfiram—alcohol dependence	0.0958	0.185	CbGbCtD
Lercanidipine—CYP3A4—Citalopram—alcohol dependence	0.0682	0.132	CbGbCtD
Lercanidipine—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.0036	0.0344	CbGpPWpGaD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00353	0.0337	CbGpPWpGaD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00292	0.0279	CbGpPWpGaD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00248	0.0237	CbGpPWpGaD
Lercanidipine—CYP3A5—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00248	0.0237	CbGpPWpGaD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00231	0.022	CbGpPWpGaD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00211	0.0202	CbGpPWpGaD
Lercanidipine—CACNA1D—forebrain—alcohol dependence	0.00205	0.0512	CbGeAlD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00193	0.0185	CbGpPWpGaD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00191	0.0183	CbGpPWpGaD
Lercanidipine—CACNA1D—adrenal cortex—alcohol dependence	0.0019	0.0474	CbGeAlD
Lercanidipine—CACNA1C—forebrain—alcohol dependence	0.00189	0.0472	CbGeAlD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00185	0.0177	CbGpPWpGaD
Lercanidipine—Nicardipine—CHRM2—alcohol dependence	0.00175	0.325	CrCbGaD
Lercanidipine—CACNA1D—cardiovascular system—alcohol dependence	0.00173	0.0433	CbGeAlD
Lercanidipine—CYP3A7—Xenobiotics—CYP2E1—alcohol dependence	0.0017	0.0162	CbGpPWpGaD
Lercanidipine—CACNA1D—pancreas—alcohol dependence	0.00168	0.0421	CbGeAlD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00162	0.0155	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0016	0.0153	CbGpPWpGaD
Lercanidipine—CACNA1C—cardiovascular system—alcohol dependence	0.0016	0.0399	CbGeAlD
Lercanidipine—CYP3A7—endocrine gland—alcohol dependence	0.00153	0.0383	CbGeAlD
Lercanidipine—Nilvadipine—CYP2E1—alcohol dependence	0.00144	0.267	CrCbGaD
Lercanidipine—CYP2D6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00141	0.0135	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0014	0.0133	CbGpPWpGaD
Lercanidipine—CYP3A7—liver—alcohol dependence	0.00138	0.0345	CbGeAlD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00138	0.0132	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00136	0.013	CbGpPWpGaD
Lercanidipine—CACNA1C—digestive system—alcohol dependence	0.00133	0.0332	CbGeAlD
Lercanidipine—Pollakiuria—Acamprosate—alcohol dependence	0.00132	0.00397	CcSEcCtD
Lercanidipine—Sweating increased—Naltrexone—alcohol dependence	0.00132	0.00396	CcSEcCtD
Lercanidipine—Angina pectoris—Naltrexone—alcohol dependence	0.00132	0.00396	CcSEcCtD
Lercanidipine—Erectile dysfunction—Acamprosate—alcohol dependence	0.00132	0.00396	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00131	0.00392	CcSEcCtD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00131	0.0125	CbGpPWpGaD
Lercanidipine—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00126	0.00377	CcSEcCtD
Lercanidipine—Cramps of lower extremities—Citalopram—alcohol dependence	0.00126	0.00377	CcSEcCtD
Lercanidipine—Myocardial infarction—Acamprosate—alcohol dependence	0.00125	0.00375	CcSEcCtD
Lercanidipine—Stomatitis—Acamprosate—alcohol dependence	0.00124	0.00373	CcSEcCtD
Lercanidipine—Urine output increased—Citalopram—alcohol dependence	0.00124	0.00371	CcSEcCtD
Lercanidipine—CYP3A5—Xenobiotics—CYP2E1—alcohol dependence	0.00123	0.0117	CbGpPWpGaD
Lercanidipine—Gynaecomastia—Citalopram—alcohol dependence	0.00122	0.00367	CcSEcCtD
Lercanidipine—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00122	0.0116	CbGpPWpGaD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00121	0.0116	CbGpPWpGaD
Lercanidipine—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00119	0.00357	CcSEcCtD
Lercanidipine—CACNA1D—endocrine gland—alcohol dependence	0.00119	0.0297	CbGeAlD
Lercanidipine—Asthenia—Disulfiram—alcohol dependence	0.00118	0.00356	CcSEcCtD
Lercanidipine—Myocardial infarction—Naltrexone—alcohol dependence	0.00118	0.00355	CcSEcCtD
Lercanidipine—CYP3A5—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00118	0.0113	CbGpPWpGaD
Lercanidipine—CYP3A7-CYP3A51P—liver—alcohol dependence	0.00118	0.0294	CbGeAlD
Lercanidipine—CYP3A5—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00117	0.0112	CbGpPWpGaD
Lercanidipine—Lymphadenopathy—Citalopram—alcohol dependence	0.00116	0.00349	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00116	0.0111	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00116	0.0111	CbGpPWpGaD
Lercanidipine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00115	0.011	CbGpPWpGaD
Lercanidipine—Rhinitis—Acamprosate—alcohol dependence	0.00115	0.00345	CcSEcCtD
Lercanidipine—Sleep disorder—Citalopram—alcohol dependence	0.00115	0.00344	CcSEcCtD
Lercanidipine—Hepatitis—Acamprosate—alcohol dependence	0.00114	0.00344	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00114	0.00343	CcSEcCtD
Lercanidipine—Diabetes mellitus—Citalopram—alcohol dependence	0.00114	0.00342	CcSEcCtD
Lercanidipine—CACNA1D—testis—alcohol dependence	0.00113	0.0283	CbGeAlD
Lercanidipine—Polyuria—Citalopram—alcohol dependence	0.00113	0.00339	CcSEcCtD
Lercanidipine—Oedema peripheral—Acamprosate—alcohol dependence	0.00113	0.00339	CcSEcCtD
Lercanidipine—CACNA1D—nervous system—alcohol dependence	0.00111	0.0278	CbGeAlD
Lercanidipine—Nifedipine—CYP2E1—alcohol dependence	0.00111	0.206	CrCbGaD
Lercanidipine—Hepatic failure—Citalopram—alcohol dependence	0.0011	0.00331	CcSEcCtD
Lercanidipine—CACNA1C—endocrine gland—alcohol dependence	0.0011	0.0274	CbGeAlD
Lercanidipine—Dizziness—Disulfiram—alcohol dependence	0.00109	0.00328	CcSEcCtD
Lercanidipine—Nicardipine—CYP2E1—alcohol dependence	0.00109	0.202	CrCbGaD
Lercanidipine—Hepatitis—Naltrexone—alcohol dependence	0.00108	0.00325	CcSEcCtD
Lercanidipine—CACNA1D—liver—alcohol dependence	0.00107	0.0268	CbGeAlD
Lercanidipine—CACNA1D—central nervous system—alcohol dependence	0.00107	0.0267	CbGeAlD
Lercanidipine—Tinnitus—Acamprosate—alcohol dependence	0.00107	0.00321	CcSEcCtD
Lercanidipine—Connective tissue disorder—Naltrexone—alcohol dependence	0.00106	0.0032	CcSEcCtD
Lercanidipine—CACNA1D—cerebellum—alcohol dependence	0.00105	0.0261	CbGeAlD
Lercanidipine—CACNA1C—testis—alcohol dependence	0.00105	0.0261	CbGeAlD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00104	0.00997	CbGpPWpGaD
Lercanidipine—Rash—Disulfiram—alcohol dependence	0.00104	0.00313	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—GRIN2B—alcohol dependence	0.00104	0.00994	CbGpPWpGaD
Lercanidipine—Headache—Disulfiram—alcohol dependence	0.00103	0.00311	CcSEcCtD
Lercanidipine—Immune system disorder—Acamprosate—alcohol dependence	0.00103	0.0031	CcSEcCtD
Lercanidipine—CACNA1C—nervous system—alcohol dependence	0.00103	0.0256	CbGeAlD
Lercanidipine—CYP3A7—Biological oxidations—ADH6—alcohol dependence	0.00103	0.00981	CbGpPWpGaD
Lercanidipine—Arthritis—Citalopram—alcohol dependence	0.00102	0.00306	CcSEcCtD
Lercanidipine—Cardiac failure—Citalopram—alcohol dependence	0.00102	0.00305	CcSEcCtD
Lercanidipine—Hypoglycaemia—Citalopram—alcohol dependence	0.00102	0.00305	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00101	0.0097	CbGpPWpGaD
Lercanidipine—Cerebrovascular accident—Citalopram—alcohol dependence	0.00101	0.00304	CcSEcCtD
Lercanidipine—Eye disorder—Naltrexone—alcohol dependence	0.00101	0.00304	CcSEcCtD
Lercanidipine—Alopecia—Acamprosate—alcohol dependence	0.00101	0.00304	CcSEcCtD
Lercanidipine—Tinnitus—Naltrexone—alcohol dependence	0.00101	0.00303	CcSEcCtD
Lercanidipine—Cardiac disorder—Naltrexone—alcohol dependence	0.00101	0.00302	CcSEcCtD
Lercanidipine—Mental disorder—Acamprosate—alcohol dependence	0.001	0.00301	CcSEcCtD
Lercanidipine—Malnutrition—Acamprosate—alcohol dependence	0.000997	0.00299	CcSEcCtD
Lercanidipine—Hyponatraemia—Citalopram—alcohol dependence	0.000996	0.00299	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000993	0.00949	CbGpPWpGaD
Lercanidipine—CACNA1C—central nervous system—alcohol dependence	0.000989	0.0247	CbGeAlD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000984	0.0094	CbGpPWpGaD
Lercanidipine—Angiopathy—Naltrexone—alcohol dependence	0.000983	0.00295	CcSEcCtD
Lercanidipine—Immune system disorder—Naltrexone—alcohol dependence	0.000979	0.00294	CcSEcCtD
Lercanidipine—Tension—Acamprosate—alcohol dependence	0.000978	0.00294	CcSEcCtD
Lercanidipine—Migraine—Citalopram—alcohol dependence	0.000977	0.00293	CcSEcCtD
Lercanidipine—Mediastinal disorder—Naltrexone—alcohol dependence	0.000976	0.00293	CcSEcCtD
Lercanidipine—Dysgeusia—Acamprosate—alcohol dependence	0.000976	0.00293	CcSEcCtD
Lercanidipine—Nervousness—Acamprosate—alcohol dependence	0.000968	0.00291	CcSEcCtD
Lercanidipine—CACNA1C—cerebellum—alcohol dependence	0.000966	0.0241	CbGeAlD
Lercanidipine—Muscle spasms—Acamprosate—alcohol dependence	0.000958	0.00288	CcSEcCtD
Lercanidipine—Face oedema—Citalopram—alcohol dependence	0.000958	0.00288	CcSEcCtD
Lercanidipine—Alopecia—Naltrexone—alcohol dependence	0.000957	0.00287	CcSEcCtD
Lercanidipine—Mental disorder—Naltrexone—alcohol dependence	0.000949	0.00285	CcSEcCtD
Lercanidipine—Malnutrition—Naltrexone—alcohol dependence	0.000943	0.00283	CcSEcCtD
Lercanidipine—Tension—Naltrexone—alcohol dependence	0.000925	0.00278	CcSEcCtD
Lercanidipine—Ill-defined disorder—Acamprosate—alcohol dependence	0.000925	0.00278	CcSEcCtD
Lercanidipine—Dysgeusia—Naltrexone—alcohol dependence	0.000923	0.00277	CcSEcCtD
Lercanidipine—Anaemia—Acamprosate—alcohol dependence	0.000921	0.00277	CcSEcCtD
Lercanidipine—Nervousness—Naltrexone—alcohol dependence	0.000916	0.00275	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—GRIN2B—alcohol dependence	0.000914	0.00873	CbGpPWpGaD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.000913	0.00873	CbGpPWpGaD
Lercanidipine—Angioedema—Acamprosate—alcohol dependence	0.000911	0.00273	CcSEcCtD
Lercanidipine—Muscle spasms—Naltrexone—alcohol dependence	0.000907	0.00272	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Citalopram—alcohol dependence	0.000906	0.00272	CcSEcCtD
Lercanidipine—Abdominal pain upper—Citalopram—alcohol dependence	0.000906	0.00272	CcSEcCtD
Lercanidipine—Malaise—Acamprosate—alcohol dependence	0.000899	0.0027	CcSEcCtD
Lercanidipine—Breast disorder—Citalopram—alcohol dependence	0.000897	0.00269	CcSEcCtD
Lercanidipine—Vertigo—Acamprosate—alcohol dependence	0.000896	0.00269	CcSEcCtD
Lercanidipine—Syncope—Acamprosate—alcohol dependence	0.000894	0.00268	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000893	0.00268	CcSEcCtD
Lercanidipine—Cramp muscle—Citalopram—alcohol dependence	0.000893	0.00268	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000893	0.00268	CcSEcCtD
Lercanidipine—Vision blurred—Naltrexone—alcohol dependence	0.000889	0.00267	CcSEcCtD
Lercanidipine—Nasopharyngitis—Citalopram—alcohol dependence	0.000887	0.00266	CcSEcCtD
Lercanidipine—Palpitations—Acamprosate—alcohol dependence	0.000881	0.00264	CcSEcCtD
Lercanidipine—Loss of consciousness—Acamprosate—alcohol dependence	0.000876	0.00263	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000875	0.00263	CcSEcCtD
Lercanidipine—Muscular weakness—Citalopram—alcohol dependence	0.000875	0.00263	CcSEcCtD
Lercanidipine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000875	0.00263	CcSEcCtD
Lercanidipine—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.000873	0.00834	CbGpPWpGaD
Lercanidipine—Cough—Acamprosate—alcohol dependence	0.00087	0.00261	CcSEcCtD
Lercanidipine—Angioedema—Naltrexone—alcohol dependence	0.000862	0.00259	CcSEcCtD
Lercanidipine—Asthma—Citalopram—alcohol dependence	0.000858	0.00257	CcSEcCtD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000853	0.00816	CbGpPWpGaD
Lercanidipine—CACNA1D—brain—alcohol dependence	0.00085	0.0212	CbGeAlD
Lercanidipine—Malaise—Naltrexone—alcohol dependence	0.00085	0.00255	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—ADH1A—alcohol dependence	0.00085	0.00813	CbGpPWpGaD
Lercanidipine—Chest pain—Acamprosate—alcohol dependence	0.000849	0.00255	CcSEcCtD
Lercanidipine—Myalgia—Acamprosate—alcohol dependence	0.000849	0.00255	CcSEcCtD
Lercanidipine—Arthralgia—Acamprosate—alcohol dependence	0.000849	0.00255	CcSEcCtD
Lercanidipine—Syncope—Naltrexone—alcohol dependence	0.000846	0.00254	CcSEcCtD
Lercanidipine—Anxiety—Acamprosate—alcohol dependence	0.000846	0.00254	CcSEcCtD
Lercanidipine—Bronchospasm—Citalopram—alcohol dependence	0.000844	0.00253	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000843	0.00253	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000841	0.00804	CbGpPWpGaD
Lercanidipine—Pancreatitis—Citalopram—alcohol dependence	0.000841	0.00252	CcSEcCtD
Lercanidipine—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000839	0.00802	CbGpPWpGaD
Lercanidipine—Discomfort—Acamprosate—alcohol dependence	0.000838	0.00252	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000837	0.008	CbGpPWpGaD
Lercanidipine—Angina pectoris—Citalopram—alcohol dependence	0.000835	0.00251	CcSEcCtD
Lercanidipine—Sweating increased—Citalopram—alcohol dependence	0.000835	0.00251	CcSEcCtD
Lercanidipine—Palpitations—Naltrexone—alcohol dependence	0.000833	0.0025	CcSEcCtD
Lercanidipine—Dry mouth—Acamprosate—alcohol dependence	0.00083	0.00249	CcSEcCtD
Lercanidipine—Loss of consciousness—Naltrexone—alcohol dependence	0.000829	0.00249	CcSEcCtD
Lercanidipine—Cough—Naltrexone—alcohol dependence	0.000823	0.00247	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000823	0.00786	CbGpPWpGaD
Lercanidipine—Confusional state—Acamprosate—alcohol dependence	0.00082	0.00246	CcSEcCtD
Lercanidipine—Pancytopenia—Citalopram—alcohol dependence	0.000814	0.00245	CcSEcCtD
Lercanidipine—Myalgia—Naltrexone—alcohol dependence	0.000803	0.00241	CcSEcCtD
Lercanidipine—Chest pain—Naltrexone—alcohol dependence	0.000803	0.00241	CcSEcCtD
Lercanidipine—Arthralgia—Naltrexone—alcohol dependence	0.000803	0.00241	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.000802	0.00767	CbGpPWpGaD
Lercanidipine—Shock—Acamprosate—alcohol dependence	0.0008	0.0024	CcSEcCtD
Lercanidipine—Anxiety—Naltrexone—alcohol dependence	0.0008	0.0024	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000797	0.00239	CcSEcCtD
Lercanidipine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000796	0.00239	CcSEcCtD
Lercanidipine—Tachycardia—Acamprosate—alcohol dependence	0.000794	0.00238	CcSEcCtD
Lercanidipine—Discomfort—Naltrexone—alcohol dependence	0.000793	0.00238	CcSEcCtD
Lercanidipine—Pollakiuria—Citalopram—alcohol dependence	0.000792	0.00238	CcSEcCtD
Lercanidipine—Skin disorder—Acamprosate—alcohol dependence	0.00079	0.00237	CcSEcCtD
Lercanidipine—Erectile dysfunction—Citalopram—alcohol dependence	0.00079	0.00237	CcSEcCtD
Lercanidipine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000786	0.00236	CcSEcCtD
Lercanidipine—Dry mouth—Naltrexone—alcohol dependence	0.000785	0.00236	CcSEcCtD
Lercanidipine—CACNA1C—brain—alcohol dependence	0.000785	0.0196	CbGeAlD
Lercanidipine—Photosensitivity reaction—Citalopram—alcohol dependence	0.000783	0.00235	CcSEcCtD
Lercanidipine—Confusional state—Naltrexone—alcohol dependence	0.000776	0.00233	CcSEcCtD
Lercanidipine—Anorexia—Acamprosate—alcohol dependence	0.000775	0.00233	CcSEcCtD
Lercanidipine—CYP3A5—pancreas—alcohol dependence	0.000765	0.0191	CbGeAlD
Lercanidipine—Hypotension—Acamprosate—alcohol dependence	0.00076	0.00228	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000758	0.00228	CcSEcCtD
Lercanidipine—Shock—Naltrexone—alcohol dependence	0.000757	0.00227	CcSEcCtD
Lercanidipine—Nervous system disorder—Naltrexone—alcohol dependence	0.000755	0.00227	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Citalopram—alcohol dependence	0.000754	0.00226	CcSEcCtD
Lercanidipine—Tachycardia—Naltrexone—alcohol dependence	0.000751	0.00226	CcSEcCtD
Lercanidipine—Myocardial infarction—Citalopram—alcohol dependence	0.000749	0.00225	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000749	0.00225	CcSEcCtD
Lercanidipine—Skin disorder—Naltrexone—alcohol dependence	0.000748	0.00224	CcSEcCtD
Lercanidipine—Jaundice—Citalopram—alcohol dependence	0.000745	0.00224	CcSEcCtD
Lercanidipine—Stomatitis—Citalopram—alcohol dependence	0.000745	0.00224	CcSEcCtD
Lercanidipine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000744	0.00223	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—ADH6—alcohol dependence	0.000742	0.00709	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000741	0.00223	CcSEcCtD
Lercanidipine—Insomnia—Acamprosate—alcohol dependence	0.000736	0.00221	CcSEcCtD
Lercanidipine—Anorexia—Naltrexone—alcohol dependence	0.000734	0.0022	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000734	0.00701	CbGpPWpGaD
Lercanidipine—Paraesthesia—Acamprosate—alcohol dependence	0.00073	0.00219	CcSEcCtD
Lercanidipine—Dyspnoea—Acamprosate—alcohol dependence	0.000725	0.00218	CcSEcCtD
Lercanidipine—Somnolence—Acamprosate—alcohol dependence	0.000723	0.00217	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Citalopram—alcohol dependence	0.000723	0.00217	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—ADH4—alcohol dependence	0.000723	0.00691	CbGpPWpGaD
Lercanidipine—Dyspepsia—Acamprosate—alcohol dependence	0.000716	0.00215	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000715	0.00683	CbGpPWpGaD
Lercanidipine—Agranulocytosis—Citalopram—alcohol dependence	0.000714	0.00214	CcSEcCtD
Lercanidipine—CYP2D6—brainstem—alcohol dependence	0.000712	0.0178	CbGeAlD
Lercanidipine—Decreased appetite—Acamprosate—alcohol dependence	0.000707	0.00212	CcSEcCtD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000705	0.00674	CbGpPWpGaD
Lercanidipine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000702	0.00211	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000701	0.00211	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.0007	0.00669	CbGpPWpGaD
Lercanidipine—Insomnia—Naltrexone—alcohol dependence	0.000696	0.00209	CcSEcCtD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000696	0.00665	CbGpPWpGaD
Lercanidipine—Constipation—Acamprosate—alcohol dependence	0.000696	0.00209	CcSEcCtD
Lercanidipine—Paraesthesia—Naltrexone—alcohol dependence	0.000691	0.00207	CcSEcCtD
Lercanidipine—Rhinitis—Citalopram—alcohol dependence	0.000688	0.00207	CcSEcCtD
Lercanidipine—CYP2D6—forebrain—alcohol dependence	0.000687	0.0172	CbGeAlD
Lercanidipine—Hepatitis—Citalopram—alcohol dependence	0.000686	0.00206	CcSEcCtD
Lercanidipine—Dyspnoea—Naltrexone—alcohol dependence	0.000686	0.00206	CcSEcCtD
Lercanidipine—Somnolence—Naltrexone—alcohol dependence	0.000684	0.00205	CcSEcCtD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000682	0.00652	CbGpPWpGaD
Lercanidipine—Urinary tract disorder—Citalopram—alcohol dependence	0.000678	0.00204	CcSEcCtD
Lercanidipine—Oedema peripheral—Citalopram—alcohol dependence	0.000676	0.00203	CcSEcCtD
Lercanidipine—Connective tissue disorder—Citalopram—alcohol dependence	0.000675	0.00203	CcSEcCtD
Lercanidipine—Urethral disorder—Citalopram—alcohol dependence	0.000673	0.00202	CcSEcCtD
Lercanidipine—Feeling abnormal—Acamprosate—alcohol dependence	0.00067	0.00201	CcSEcCtD
Lercanidipine—Decreased appetite—Naltrexone—alcohol dependence	0.000669	0.00201	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000665	0.002	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000664	0.00199	CcSEcCtD
Lercanidipine—Fatigue—Naltrexone—alcohol dependence	0.000664	0.00199	CcSEcCtD
Lercanidipine—Constipation—Naltrexone—alcohol dependence	0.000658	0.00198	CcSEcCtD
Lercanidipine—CYP3A5—digestive system—alcohol dependence	0.000653	0.0163	CbGeAlD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000649	0.0062	CbGpPWpGaD
Lercanidipine—Erythema multiforme—Citalopram—alcohol dependence	0.000649	0.00195	CcSEcCtD
Lercanidipine—Urticaria—Acamprosate—alcohol dependence	0.000646	0.00194	CcSEcCtD
Lercanidipine—Abdominal pain—Acamprosate—alcohol dependence	0.000643	0.00193	CcSEcCtD
Lercanidipine—Body temperature increased—Acamprosate—alcohol dependence	0.000643	0.00193	CcSEcCtD
Lercanidipine—Eye disorder—Citalopram—alcohol dependence	0.000641	0.00193	CcSEcCtD
Lercanidipine—Tinnitus—Citalopram—alcohol dependence	0.00064	0.00192	CcSEcCtD
Lercanidipine—Flushing—Citalopram—alcohol dependence	0.000637	0.00191	CcSEcCtD
Lercanidipine—Cardiac disorder—Citalopram—alcohol dependence	0.000637	0.00191	CcSEcCtD
Lercanidipine—Feeling abnormal—Naltrexone—alcohol dependence	0.000634	0.0019	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000629	0.00189	CcSEcCtD
Lercanidipine—Angiopathy—Citalopram—alcohol dependence	0.000623	0.00187	CcSEcCtD
Lercanidipine—CYP3A5—blood—alcohol dependence	0.000622	0.0155	CbGeAlD
Lercanidipine—Immune system disorder—Citalopram—alcohol dependence	0.00062	0.00186	CcSEcCtD
Lercanidipine—Mediastinal disorder—Citalopram—alcohol dependence	0.000619	0.00186	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—ADH7—alcohol dependence	0.000615	0.00588	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—ADH1A—alcohol dependence	0.000615	0.00587	CbGpPWpGaD
Lercanidipine—Urticaria—Naltrexone—alcohol dependence	0.000611	0.00184	CcSEcCtD
Lercanidipine—Abdominal pain—Naltrexone—alcohol dependence	0.000608	0.00183	CcSEcCtD
Lercanidipine—Body temperature increased—Naltrexone—alcohol dependence	0.000608	0.00183	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000608	0.00581	CbGpPWpGaD
Lercanidipine—Alopecia—Citalopram—alcohol dependence	0.000607	0.00182	CcSEcCtD
Lercanidipine—Mental disorder—Citalopram—alcohol dependence	0.000601	0.00181	CcSEcCtD
Lercanidipine—Hypersensitivity—Acamprosate—alcohol dependence	0.000599	0.0018	CcSEcCtD
Lercanidipine—Erythema—Citalopram—alcohol dependence	0.000598	0.00179	CcSEcCtD
Lercanidipine—Malnutrition—Citalopram—alcohol dependence	0.000598	0.00179	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000595	0.00569	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—GGT2—alcohol dependence	0.000589	0.00563	CbGpPWpGaD
Lercanidipine—Tension—Citalopram—alcohol dependence	0.000586	0.00176	CcSEcCtD
Lercanidipine—Dysgeusia—Citalopram—alcohol dependence	0.000585	0.00176	CcSEcCtD
Lercanidipine—Asthenia—Acamprosate—alcohol dependence	0.000584	0.00175	CcSEcCtD
Lercanidipine—Nervousness—Citalopram—alcohol dependence	0.00058	0.00174	CcSEcCtD
Lercanidipine—Pruritus—Acamprosate—alcohol dependence	0.000576	0.00173	CcSEcCtD
Lercanidipine—Muscle spasms—Citalopram—alcohol dependence	0.000574	0.00172	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000572	0.00546	CbGpPWpGaD
Lercanidipine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000571	0.00545	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Naltrexone—alcohol dependence	0.000567	0.0017	CcSEcCtD
Lercanidipine—Vision blurred—Citalopram—alcohol dependence	0.000563	0.00169	CcSEcCtD
Lercanidipine—Diarrhoea—Acamprosate—alcohol dependence	0.000557	0.00167	CcSEcCtD
Lercanidipine—Ill-defined disorder—Citalopram—alcohol dependence	0.000554	0.00166	CcSEcCtD
Lercanidipine—Anaemia—Citalopram—alcohol dependence	0.000552	0.00166	CcSEcCtD
Lercanidipine—Asthenia—Naltrexone—alcohol dependence	0.000552	0.00166	CcSEcCtD
Lercanidipine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000549	0.00524	CbGpPWpGaD
Lercanidipine—Angioedema—Citalopram—alcohol dependence	0.000546	0.00164	CcSEcCtD
Lercanidipine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000546	0.00522	CbGpPWpGaD
Lercanidipine—Pruritus—Naltrexone—alcohol dependence	0.000545	0.00163	CcSEcCtD
Lercanidipine—CYP3A5—endocrine gland—alcohol dependence	0.00054	0.0135	CbGeAlD
Lercanidipine—CYP3A7—Biological oxidations—ADH1B—alcohol dependence	0.000539	0.00515	CbGpPWpGaD
Lercanidipine—Malaise—Citalopram—alcohol dependence	0.000539	0.00162	CcSEcCtD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000538	0.00514	CbGpPWpGaD
Lercanidipine—Dizziness—Acamprosate—alcohol dependence	0.000538	0.00162	CcSEcCtD
Lercanidipine—Vertigo—Citalopram—alcohol dependence	0.000537	0.00161	CcSEcCtD
Lercanidipine—Syncope—Citalopram—alcohol dependence	0.000536	0.00161	CcSEcCtD
Lercanidipine—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000533	0.0051	CbGpPWpGaD
Lercanidipine—Palpitations—Citalopram—alcohol dependence	0.000528	0.00159	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000527	0.00504	CbGpPWpGaD
Lercanidipine—Diarrhoea—Naltrexone—alcohol dependence	0.000527	0.00158	CcSEcCtD
Lercanidipine—Loss of consciousness—Citalopram—alcohol dependence	0.000525	0.00158	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—ADH4—alcohol dependence	0.000523	0.00499	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000522	0.00499	CbGpPWpGaD
Lercanidipine—Cough—Citalopram—alcohol dependence	0.000521	0.00157	CcSEcCtD
Lercanidipine—Vomiting—Acamprosate—alcohol dependence	0.000517	0.00155	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000517	0.00494	CbGpPWpGaD
Lercanidipine—Rash—Acamprosate—alcohol dependence	0.000513	0.00154	CcSEcCtD
Lercanidipine—Dermatitis—Acamprosate—alcohol dependence	0.000512	0.00154	CcSEcCtD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00051	0.00487	CbGpPWpGaD
Lercanidipine—Headache—Acamprosate—alcohol dependence	0.00051	0.00153	CcSEcCtD
Lercanidipine—Dizziness—Naltrexone—alcohol dependence	0.000509	0.00153	CcSEcCtD
Lercanidipine—Myalgia—Citalopram—alcohol dependence	0.000509	0.00153	CcSEcCtD
Lercanidipine—Chest pain—Citalopram—alcohol dependence	0.000509	0.00153	CcSEcCtD
Lercanidipine—Arthralgia—Citalopram—alcohol dependence	0.000509	0.00153	CcSEcCtD
Lercanidipine—Anxiety—Citalopram—alcohol dependence	0.000507	0.00152	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000505	0.00152	CcSEcCtD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000503	0.00481	CbGpPWpGaD
Lercanidipine—Discomfort—Citalopram—alcohol dependence	0.000503	0.00151	CcSEcCtD
Lercanidipine—Dry mouth—Citalopram—alcohol dependence	0.000498	0.00149	CcSEcCtD
Lercanidipine—Confusional state—Citalopram—alcohol dependence	0.000492	0.00148	CcSEcCtD
Lercanidipine—CYP3A4—digestive system—alcohol dependence	0.00049	0.0122	CbGeAlD
Lercanidipine—Vomiting—Naltrexone—alcohol dependence	0.000489	0.00147	CcSEcCtD
Lercanidipine—CYP3A5—liver—alcohol dependence	0.000487	0.0122	CbGeAlD
Lercanidipine—Rash—Naltrexone—alcohol dependence	0.000485	0.00146	CcSEcCtD
Lercanidipine—Dermatitis—Naltrexone—alcohol dependence	0.000485	0.00146	CcSEcCtD
Lercanidipine—Nausea—Acamprosate—alcohol dependence	0.000483	0.00145	CcSEcCtD
Lercanidipine—CYP2D6—digestive system—alcohol dependence	0.000483	0.012	CbGeAlD
Lercanidipine—Headache—Naltrexone—alcohol dependence	0.000482	0.00145	CcSEcCtD
Lercanidipine—Shock—Citalopram—alcohol dependence	0.00048	0.00144	CcSEcCtD
Lercanidipine—Nervous system disorder—Citalopram—alcohol dependence	0.000478	0.00144	CcSEcCtD
Lercanidipine—Thrombocytopenia—Citalopram—alcohol dependence	0.000477	0.00143	CcSEcCtD
Lercanidipine—Tachycardia—Citalopram—alcohol dependence	0.000476	0.00143	CcSEcCtD
Lercanidipine—Skin disorder—Citalopram—alcohol dependence	0.000474	0.00142	CcSEcCtD
Lercanidipine—Hyperhidrosis—Citalopram—alcohol dependence	0.000471	0.00142	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00047	0.00449	CbGpPWpGaD
Lercanidipine—CYP3A4—blood—alcohol dependence	0.000467	0.0117	CbGeAlD
Lercanidipine—Anorexia—Citalopram—alcohol dependence	0.000465	0.0014	CcSEcCtD
Lercanidipine—CYP2D6—blood—alcohol dependence	0.00046	0.0115	CbGeAlD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000457	0.00437	CbGpPWpGaD
Lercanidipine—Nausea—Naltrexone—alcohol dependence	0.000457	0.00137	CcSEcCtD
Lercanidipine—Hypotension—Citalopram—alcohol dependence	0.000456	0.00137	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—MAOB—alcohol dependence	0.000447	0.00427	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000444	0.00425	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000444	0.00133	CcSEcCtD
Lercanidipine—Insomnia—Citalopram—alcohol dependence	0.000441	0.00132	CcSEcCtD
Lercanidipine—Paraesthesia—Citalopram—alcohol dependence	0.000438	0.00131	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000437	0.00418	CbGpPWpGaD
Lercanidipine—Dyspnoea—Citalopram—alcohol dependence	0.000435	0.00131	CcSEcCtD
Lercanidipine—Somnolence—Citalopram—alcohol dependence	0.000434	0.0013	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000432	0.00413	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000431	0.00412	CbGpPWpGaD
Lercanidipine—Dyspepsia—Citalopram—alcohol dependence	0.000429	0.00129	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.000426	0.00407	CbGpPWpGaD
Lercanidipine—Decreased appetite—Citalopram—alcohol dependence	0.000424	0.00127	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000421	0.00126	CcSEcCtD
Lercanidipine—Fatigue—Citalopram—alcohol dependence	0.00042	0.00126	CcSEcCtD
Lercanidipine—Constipation—Citalopram—alcohol dependence	0.000417	0.00125	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000413	0.00395	CbGpPWpGaD
Lercanidipine—CYP3A4—endocrine gland—alcohol dependence	0.000405	0.0101	CbGeAlD
Lercanidipine—Feeling abnormal—Citalopram—alcohol dependence	0.000402	0.00121	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000399	0.0012	CcSEcCtD
Lercanidipine—CYP2D6—endocrine gland—alcohol dependence	0.000399	0.00995	CbGeAlD
Lercanidipine—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.00039	0.00372	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000389	0.00372	CbGpPWpGaD
Lercanidipine—Urticaria—Citalopram—alcohol dependence	0.000387	0.00116	CcSEcCtD
Lercanidipine—Body temperature increased—Citalopram—alcohol dependence	0.000386	0.00116	CcSEcCtD
Lercanidipine—Abdominal pain—Citalopram—alcohol dependence	0.000386	0.00116	CcSEcCtD
Lercanidipine—CYP2D6—testis—alcohol dependence	0.00038	0.00949	CbGeAlD
Lercanidipine—CYP3A7—Biological oxidations—ALDH2—alcohol dependence	0.00038	0.00363	CbGpPWpGaD
Lercanidipine—CYP3A4—nervous system—alcohol dependence	0.000379	0.00947	CbGeAlD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000378	0.00361	CbGpPWpGaD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000373	0.00357	CbGpPWpGaD
Lercanidipine—CYP2D6—nervous system—alcohol dependence	0.000373	0.00932	CbGeAlD
Lercanidipine—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000372	0.00355	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000367	0.00351	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000367	0.0035	CbGpPWpGaD
Lercanidipine—CYP3A4—liver—alcohol dependence	0.000365	0.00912	CbGeAlD
Lercanidipine—CYP3A4—central nervous system—alcohol dependence	0.000365	0.00912	CbGeAlD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000362	0.00346	CbGpPWpGaD
Lercanidipine—CYP2D6—liver—alcohol dependence	0.000359	0.00897	CbGeAlD
Lercanidipine—CYP2D6—central nervous system—alcohol dependence	0.000359	0.00897	CbGeAlD
Lercanidipine—Hypersensitivity—Citalopram—alcohol dependence	0.000359	0.00108	CcSEcCtD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000358	0.00342	CbGpPWpGaD
Lercanidipine—CYP2D6—cerebellum—alcohol dependence	0.000351	0.00877	CbGeAlD
Lercanidipine—Asthenia—Citalopram—alcohol dependence	0.00035	0.00105	CcSEcCtD
Lercanidipine—Pruritus—Citalopram—alcohol dependence	0.000345	0.00104	CcSEcCtD
Lercanidipine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000345	0.0033	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000341	0.00326	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00034	0.00325	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—GRIN2B—alcohol dependence	0.000336	0.00321	CbGpPWpGaD
Lercanidipine—Diarrhoea—Citalopram—alcohol dependence	0.000334	0.001	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—ADH6—alcohol dependence	0.000326	0.00312	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000323	0.00309	CbGpPWpGaD
Lercanidipine—Dizziness—Citalopram—alcohol dependence	0.000322	0.000968	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000316	0.00302	CbGpPWpGaD
Lercanidipine—Vomiting—Citalopram—alcohol dependence	0.00031	0.000931	CcSEcCtD
Lercanidipine—Rash—Citalopram—alcohol dependence	0.000307	0.000923	CcSEcCtD
Lercanidipine—Dermatitis—Citalopram—alcohol dependence	0.000307	0.000922	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000306	0.00293	CbGpPWpGaD
Lercanidipine—Headache—Citalopram—alcohol dependence	0.000306	0.000917	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—CYP2E1—alcohol dependence	0.000304	0.0029	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000303	0.0029	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000299	0.00286	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—GRIN2B—alcohol dependence	0.000295	0.00282	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000294	0.00281	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000293	0.0028	CbGpPWpGaD
Lercanidipine—Nausea—Citalopram—alcohol dependence	0.00029	0.00087	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—ADH6—alcohol dependence	0.000287	0.00274	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000286	0.00273	CbGpPWpGaD
Lercanidipine—CYP2D6—brain—alcohol dependence	0.000285	0.00712	CbGeAlD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000283	0.0027	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—GGT1—alcohol dependence	0.000279	0.00266	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000277	0.00265	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000275	0.00262	CbGpPWpGaD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000273	0.00261	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADH1A—alcohol dependence	0.00027	0.00258	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—MAOA—alcohol dependence	0.00025	0.00239	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000243	0.00232	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000242	0.00231	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00024	0.0023	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—GRIN2B—alcohol dependence	0.00024	0.00229	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADH1A—alcohol dependence	0.000237	0.00227	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000237	0.00226	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000234	0.00223	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADH4—alcohol dependence	0.00023	0.0022	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.00023	0.00219	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000221	0.00212	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000219	0.0021	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000216	0.00207	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—GRIN2B—alcohol dependence	0.000211	0.00201	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000207	0.00197	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADH4—alcohol dependence	0.000202	0.00193	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—GGT1—alcohol dependence	0.000201	0.00193	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000198	0.00189	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADH7—alcohol dependence	0.000195	0.00187	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000195	0.00187	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000194	0.00186	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000192	0.00184	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GGT2—alcohol dependence	0.000187	0.00179	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000181	0.00173	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—MAOA—alcohol dependence	0.000181	0.00173	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH6—alcohol dependence	0.000175	0.00168	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADH7—alcohol dependence	0.000172	0.00164	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADH1B—alcohol dependence	0.000171	0.00164	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GGT2—alcohol dependence	0.000165	0.00157	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—POMC—alcohol dependence	0.000163	0.00155	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000158	0.00151	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000157	0.0015	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000156	0.00149	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000154	0.00147	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADH1B—alcohol dependence	0.000151	0.00144	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.00015	0.00143	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH1A—alcohol dependence	0.000145	0.00139	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000143	0.00137	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MAOB—alcohol dependence	0.000142	0.00136	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000128	0.00123	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000128	0.00122	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000127	0.00121	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH6—alcohol dependence	0.000127	0.00121	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MAOB—alcohol dependence	0.000125	0.00119	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH4—alcohol dependence	0.000124	0.00118	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALDH2—alcohol dependence	0.000121	0.00115	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—POMC—alcohol dependence	0.000118	0.00112	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALDH2—alcohol dependence	0.000106	0.00101	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH7—alcohol dependence	0.000105	0.001	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH1A—alcohol dependence	0.000105	0.001	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000103	0.000983	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GOT2—alcohol dependence	0.000103	0.000981	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000102	0.000975	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GGT2—alcohol dependence	0.000101	0.000963	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000101	0.000962	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP2E1—alcohol dependence	9.65e-05	0.000922	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	9.37e-05	0.000895	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH1B—alcohol dependence	9.22e-05	0.000881	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH6—alcohol dependence	9.02e-05	0.000862	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GOT2—alcohol dependence	9.02e-05	0.000862	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH4—alcohol dependence	8.94e-05	0.000854	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GOT1—alcohol dependence	8.86e-05	0.000847	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GGT1—alcohol dependence	8.86e-05	0.000847	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EP300—alcohol dependence	8.62e-05	0.000824	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2E1—alcohol dependence	8.48e-05	0.00081	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	8.39e-05	0.000802	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—POMC—alcohol dependence	8.36e-05	0.000799	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MAOA—alcohol dependence	7.94e-05	0.000759	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GOT1—alcohol dependence	7.78e-05	0.000744	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GGT1—alcohol dependence	7.78e-05	0.000744	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MAOB—alcohol dependence	7.64e-05	0.00073	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH7—alcohol dependence	7.6e-05	0.000726	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EP300—alcohol dependence	7.58e-05	0.000724	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH1A—alcohol dependence	7.47e-05	0.000714	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GGT2—alcohol dependence	7.29e-05	0.000696	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MAOA—alcohol dependence	6.98e-05	0.000667	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH1B—alcohol dependence	6.66e-05	0.000637	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALDH2—alcohol dependence	6.49e-05	0.000621	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH4—alcohol dependence	6.36e-05	0.000607	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH6—alcohol dependence	5.9e-05	0.000564	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GOT2—alcohol dependence	5.52e-05	0.000528	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MAOB—alcohol dependence	5.52e-05	0.000528	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—POMC—alcohol dependence	5.47e-05	0.000522	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH7—alcohol dependence	5.4e-05	0.000516	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2E1—alcohol dependence	5.19e-05	0.000496	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GGT2—alcohol dependence	5.18e-05	0.000495	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—POMC—alcohol dependence	5.17e-05	0.000494	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.89e-05	0.000467	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GOT1—alcohol dependence	4.77e-05	0.000456	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GGT1—alcohol dependence	4.77e-05	0.000456	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH1B—alcohol dependence	4.74e-05	0.000453	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALDH2—alcohol dependence	4.69e-05	0.000449	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—POMC—alcohol dependence	4.54e-05	0.000434	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MAOA—alcohol dependence	4.27e-05	0.000408	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH4—alcohol dependence	4.16e-05	0.000397	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GOT2—alcohol dependence	3.99e-05	0.000382	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MAOB—alcohol dependence	3.93e-05	0.000375	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2E1—alcohol dependence	3.75e-05	0.000359	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH7—alcohol dependence	3.53e-05	0.000338	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GGT1—alcohol dependence	3.45e-05	0.000329	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GOT1—alcohol dependence	3.45e-05	0.000329	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—EP300—alcohol dependence	3.43e-05	0.000328	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GGT2—alcohol dependence	3.39e-05	0.000324	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALDH2—alcohol dependence	3.34e-05	0.000319	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.1e-05	0.000296	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MAOA—alcohol dependence	3.09e-05	0.000295	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—EP300—alcohol dependence	3.01e-05	0.000288	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GOT2—alcohol dependence	2.84e-05	0.000271	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—POMC—alcohol dependence	2.78e-05	0.000266	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.67e-05	0.000255	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MAOB—alcohol dependence	2.57e-05	0.000245	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GGT1—alcohol dependence	2.45e-05	0.000234	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GOT1—alcohol dependence	2.45e-05	0.000234	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MAOA—alcohol dependence	2.2e-05	0.00021	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.18e-05	0.000209	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—POMC—alcohol dependence	2.01e-05	0.000192	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.86e-05	0.000177	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—EP300—alcohol dependence	1.85e-05	0.000176	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.74e-05	0.000167	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GOT1—alcohol dependence	1.6e-05	0.000153	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GGT1—alcohol dependence	1.6e-05	0.000153	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MAOA—alcohol dependence	1.44e-05	0.000137	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—POMC—alcohol dependence	1.43e-05	0.000137	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—EP300—alcohol dependence	1.33e-05	0.000127	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—EP300—alcohol dependence	9.48e-06	9.06e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—POMC—alcohol dependence	9.35e-06	8.93e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—EP300—alcohol dependence	6.2e-06	5.93e-05	CbGpPWpGaD
